Proyectos destacados

Lipid droplets as key players in brain microgliosis after stroke

Investigador/a principal: Albert Pol Sorolla.
Financiador: La Caixa Foundation .

Código: HR23-00560.

Duración: 21/12/2023 - 30/12/2026
Lipid droplets as innate immunity hubs

Investigador/a principal: Albert Pol Sorolla.
Financiador: European Commission .

Código: CE_HE_ERC_2022_SyG.

Duración: 01/01/2023 - 31/12/2028
Mapping the innate immunity defences organised on lipid droplets

Investigador/a principal: Albert Pol Sorolla.
Financiador: Agencia Estatal de Investigación .

Código: PID2021-127043OB-I00.

Duración: 01/09/2022 - 31/08/2025
EU Training Network in understanding the molecular regulation and the role of endo-lysosomal (EndoConnect)

Investigador/a principal: Albert Pol Sorolla.
Financiador: European Commission .

Código: CE_H2020-MSCA-ITN-20.

Duración: 01/01/2021 - 31/03/2025
Discovering the Partners of PCSK9 in Hepatic Endosomes: The Where, How, and Why of PCSK9 in Atherosclerosis.

Investigador/a principal: Albert Pol Sorolla.
Financiador: AMGEN, Inc .

Código: INT_AMGEN_PCSK9_18.

Duración: 01/09/2018 - 31/08/2021
Lipid Droplet Overloading Promotes Pathogenesis and Progression of Type 2 Diabetes: Identifying New Therapeutic Targets and Applying Upgraded Therapies

Investigador/a principal: Albert Pol Sorolla.
Financiador: Fundació La Marató de TV3 .

Duración: 24/02/2017 - 23/10/2020
Mammalian lipid droplets: a central role in the organismal antibacterial response?

Investigador/a principal: Albert Pol Sorolla.
Financiador: Human Frontier Science Program (HFSP) .

Código: RGP0020/2015.

Duración: 01/06/2015 - 30/11/2018

La investigación de este grupo se puede llevar a cabo gracias a los financiadores.

Proyectos destacados

Lipid droplets as key players in brain microgliosis after stroke

Lipid droplets as innate immunity hubs

Mapping the innate immunity defences organised on lipid droplets

EU Training Network in understanding the molecular regulation and the role of endo-lysosomal (EndoConnect)

Discovering the Partners of PCSK9 in Hepatic Endosomes: The Where, How, and Why of PCSK9 in Atherosclerosis.

Lipid Droplet Overloading Promotes Pathogenesis and Progression of Type 2 Diabetes: Identifying New Therapeutic Targets and Applying Upgraded Therapies

Mammalian lipid droplets: a central role in the organismal antibacterial response?

Principales financiadores